Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
COG1-CDG is an extremely rare form of CDG syndrome characterized clinically in the few cases reported to date by variable signs including microcephaly, growth retardation, psychomotor retardation and facial dysmorphism.
Features include always present findings: Failure to thrive in infancy, Low muscle tone (hypotonia), Microcephaly, and Global developmental delay and others; and common findings: Broad femoral neck, Short stature, Hemolytic-uremic syndrome, and Reduced kidney function (renal insufficiency) and others. 89 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 10 | Broad femoral neck, Kyphoscoliosis, Butterfly vertebrae |
COG1 encodes component of oligomeric golgi complex 1 (980 aa). Required for normal Golgi function Highest expression in Brain Cerebellum (69.8 TPM) and Brain Cerebellar Hemisphere (65.9 TPM).
COG1-congenital disorder of glycosylation has been associated with mutations in the COG1 gene on chromosome 17.
COG1 is classified as a druggable target with score 0.0.
Genetic testing for COG1 is available. Testing is considered supportive for diagnosis.
Phenotype severity distribution: 11 always present features, 51 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 1:22 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about COG1-congenital disorder of glycosylation
Brain and nerves | 7 | Moderate intellectual disability, Mild global developmental delay, Global developmental delay |
Head and neck | 7 | Progressive microcephaly, Cleft palate, Microcephaly |
Muscles | 6 | Low muscle tone (hypotonia), Shrinkage of the cerebellum (cerebellar atrophy), Brain atrophy |
Growth and development | 5 | Failure to thrive in infancy, Short stature, Postnatal growth retardation |
Blood and immune system | 5 | Hemolytic-uremic syndrome, Recurrent infections, Low red blood cell count (anemia) |
Arms and legs | 3 | Short foot, Ulnar deviation of finger, Small hand |
Digestive system | 3 | Feeding difficulties in infancy, Cholesteatoma, Hepatosplenomegaly |
Heart and blood vessels | 3 | Thickened left heart wall (left ventricular hypertrophy), High blood pressure in lung arteries (pulmonary arterial hypertension), Atrial septal dilatation |
Kidneys and urinary system | 1 | Reduced kidney function (renal insufficiency) |
Ears | 1 | Conductive hearing impairment |
Eyes | 1 | Abnormal central area of the retina (abnormal macular morphology) |
Lungs and breathing | 1 | High blood pressure in lung arteries (pulmonary arterial hypertension) |
Age of onset: childhood, infancy.